SFA
KZIA

Sequoia Financial Advisors’s Kazia Therapeutics KZIA Stock Holding History

Sequoia Financial Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
20,003
-39,997
-67% -$487K ﹤0.01% 1718
2026
Q1 		$446K Buy
+60,000
New +$418K ﹤0.01% 1334

Other funds holding KZIA

WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $853M AUM 34.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Sequoia Financial Advisors's KZIA Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Kazia Therapeutics (KZIA) stake by 67% in Q2 2026, selling an estimated $487K and leaving 20,003 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Sequoia Financial Advisors first reported a position in KZIA in Q1 2026 and has held it in 2 quarters since. The position peaked at $446K in Q1 2026. 5 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Sequoia Financial Advisors held 20,003 shares of Kazia Therapeutics worth $282K as of Q2 2026.
  • Sequoia Financial Advisors sold 39,997 Kazia Therapeutics shares in Q2 2026, an estimated $487K.
  • Kazia Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1718 holding.
  • Sequoia Financial Advisors first reported a position in Kazia Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Sequoia Financial Advisors's Kazia Therapeutics position peaked at $446K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.